Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cryopyrin-Associated Periodic Syndromes

• A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)
• Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)
• Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
• Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
• A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
• Efficacy and Safety of Ucha-Shinki-Hwan on Korean Patients With Cold Hypersensitivity in the Hands and Feet-Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial
• Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)
• Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and Feet
• HL2351 CAPS Phase II Study
• Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands
• Kineret CAPS Post Authorisation Study
• Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet
• Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
• A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
• The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
• Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
• Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
• Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
• Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
• Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome
• Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
• The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
• Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease